LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $312,000 | -12.8% | 3,134 | 0.0% | 0.01% | -7.7% |
| Q2 2019 | $358,000 | +0.6% | 3,134 | +10.6% | 0.01% | -7.1% |
| Q1 2019 | $356,000 | -7.5% | 2,834 | 0.0% | 0.01% | -17.6% |
| Q4 2018 | $385,000 | -50.5% | 2,834 | 0.0% | 0.02% | -39.3% |
| Q3 2018 | $778,000 | +32.5% | 2,834 | 0.0% | 0.03% | +21.7% |
| Q2 2018 | $587,000 | +25.4% | 2,834 | 0.0% | 0.02% | +15.0% |
| Q1 2018 | $468,000 | +20.6% | 2,834 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $388,000 | +27.6% | 2,834 | +26.9% | 0.02% | +14.3% |
| Q3 2017 | $304,000 | +39.4% | 2,234 | +24.2% | 0.01% | +27.3% |
| Q2 2017 | $218,000 | +129.5% | 1,798 | +99.8% | 0.01% | +120.0% |
| Q1 2017 | $95,000 | +17.3% | 900 | +12.5% | 0.01% | 0.0% |
| Q4 2016 | $81,000 | -1.2% | 800 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $82,000 | -86.5% | 800 | -94.8% | 0.01% | -50.0% |
| Q2 2016 | $608,000 | +78.8% | 15,312 | +383.3% | 0.01% | +100.0% |
| Q1 2016 | $340,000 | -12.8% | 3,168 | -12.0% | 0.01% | -16.7% |
| Q4 2015 | $390,000 | +314.9% | 3,600 | +227.3% | 0.01% | +500.0% |
| Q3 2015 | $94,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |